SCHEMBL9694313

SCHEMBL9694313

CCOC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C=O)c2)CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.63
ALDH1A1 P00352 3/20 0.63
SMN1; SMN2 Q16637 2/20 0.63
LMNA P02545 2/20 0.63
MAPK1 P28482 1/20 0.55
HTT P42858 1/20 0.55
KDM4E B2RXH2 2/20 0.53
GAA P10253 1/20 0.53
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
GPR174 Q9BXC1 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.50
DCTPP1 Q9H773 2/20 0.47
PDE3B Q13370 1/20 0.46
PDE3A Q14432 1/20 0.46
NPC1 O15118 1/20 0.46
MTOR P42345 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14227607 0.86 TMEM97 (0.51) MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL13278356 0.85 MAPT (0.64) MAPTALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL9692032 0.84 MAPT (0.72) MAPTALDH1A1HTTKDM4EGAA
SCHEMBL13278197 0.83 MAPT (0.48) MAPTALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL13278196 0.83 MAPT (0.48) MAPTALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL9691823 0.82 MAPT (0.53) MAPTALDH1A1SMN1; SMN2LMNAMAPK1
SCHEMBL9691817 0.82 MAPT (0.53) MAPTALDH1A1SMN1; SMN2LMNAMAPK1
SCHEMBL28868212 0.80 MAPT (0.63) MAPTALDH1A1SMN1; SMN2LMNAMAPK1
SCHEMBL3214435 0.79 SIRT6 (0.66) MAPTALDH1A1MAPK1L3MBTL1
SCHEMBL5754936 0.79 MAPT (0.74) MAPTALDH1A1SMN1; SMN2LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0252503-B1 AMINOIMIDAZOQUINOLINE DERIVATIVES Bristol-Myers Squibb Company (US) 1992-11-19 EP disclosed
EP-0252503-A1 Aminoimidazoquinoline derivatives Bristol-Myers Squibb Company (US) 1988-01-13 EP disclosed
US-4701459-A 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation BRISTOL-MYERS COMPANY (US) 1987-10-20 US disclosed